

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 4.92454222 |
| 2 | ribosomal small subunit biogenesis (GO:0042274) | 4.67039822 |
| 3 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.66504626 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.34562899 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.17741071 |
| 6 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.78452335 |
| 7 | regulation of mitochondrial translation (GO:0070129) | 3.75040916 |
| 8 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.70615641 |
| 9 | viral transcription (GO:0019083) | 3.59997743 |
| 10 | deoxyribonucleotide catabolic process (GO:0009264) | 3.54125980 |
| 11 | NIK/NF-kappaB signaling (GO:0038061) | 3.48041709 |
| 12 | deoxyribose phosphate catabolic process (GO:0046386) | 3.43242165 |
| 13 | translational termination (GO:0006415) | 3.27255256 |
| 14 | nucleotide salvage (GO:0043173) | 3.18324471 |
| 15 | translational elongation (GO:0006414) | 3.17247821 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 3.15036017 |
| 17 | base-excision repair, AP site formation (GO:0006285) | 3.14706966 |
| 18 | purine nucleotide salvage (GO:0032261) | 3.12035948 |
| 19 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.09506752 |
| 20 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.05879357 |
| 21 | pseudouridine synthesis (GO:0001522) | 3.05475237 |
| 22 | pentose metabolic process (GO:0019321) | 3.05443683 |
| 23 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.03460921 |
| 24 | nuclear envelope reassembly (GO:0031468) | 3.01295038 |
| 25 | mitotic nuclear envelope reassembly (GO:0007084) | 3.01295038 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 3.01206055 |
| 27 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.00832518 |
| 28 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.99720509 |
| 29 | protein targeting to ER (GO:0045047) | 2.97944780 |
| 30 | negative regulation of B cell apoptotic process (GO:0002903) | 2.96982013 |
| 31 | viral life cycle (GO:0019058) | 2.92955281 |
| 32 | protein localization to endoplasmic reticulum (GO:0070972) | 2.92739649 |
| 33 | cotranslational protein targeting to membrane (GO:0006613) | 2.91322306 |
| 34 | UV protection (GO:0009650) | 2.89602621 |
| 35 | pyrimidine-containing compound salvage (GO:0008655) | 2.86226508 |
| 36 | pyrimidine nucleoside salvage (GO:0043097) | 2.86226508 |
| 37 | proteasome assembly (GO:0043248) | 2.85964398 |
| 38 | nucleoside salvage (GO:0043174) | 2.83673318 |
| 39 | protein targeting to mitochondrion (GO:0006626) | 2.81789460 |
| 40 | rRNA modification (GO:0000154) | 2.81075498 |
| 41 | positive regulation of T cell apoptotic process (GO:0070234) | 2.79870864 |
| 42 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.79386055 |
| 43 | proline biosynthetic process (GO:0006561) | 2.79146681 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.78246393 |
| 45 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.77026611 |
| 46 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.75501977 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.74301295 |
| 48 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.73908757 |
| 49 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.72828291 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 2.70272825 |
| 51 | COPI coating of Golgi vesicle (GO:0048205) | 2.70272825 |
| 52 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.70001186 |
| 53 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.70001186 |
| 54 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.69180065 |
| 55 | establishment of protein localization to mitochondrion (GO:0072655) | 2.68703381 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.67515496 |
| 57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.66446836 |
| 58 | metallo-sulfur cluster assembly (GO:0031163) | 2.65450391 |
| 59 | iron-sulfur cluster assembly (GO:0016226) | 2.65450391 |
| 60 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.65368381 |
| 61 | DNA deamination (GO:0045006) | 2.63612793 |
| 62 | UTP biosynthetic process (GO:0006228) | 2.63031286 |
| 63 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.61658689 |
| 64 | deoxyribose phosphate metabolic process (GO:0019692) | 2.61348246 |
| 65 | transcription from mitochondrial promoter (GO:0006390) | 2.61066658 |
| 66 | chaperone-mediated protein transport (GO:0072321) | 2.60796072 |
| 67 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.60342429 |
| 68 | ATP synthesis coupled proton transport (GO:0015986) | 2.60342429 |
| 69 | protein complex biogenesis (GO:0070271) | 2.58932324 |
| 70 | GTP biosynthetic process (GO:0006183) | 2.58289747 |
| 71 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.58065715 |
| 72 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.57907174 |
| 73 | negative regulation of ligase activity (GO:0051352) | 2.57023104 |
| 74 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.57023104 |
| 75 | oxidative phosphorylation (GO:0006119) | 2.56852003 |
| 76 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56451159 |
| 77 | cellular protein complex disassembly (GO:0043624) | 2.55241713 |
| 78 | amino sugar catabolic process (GO:0046348) | 2.54562036 |
| 79 | cellular component biogenesis (GO:0044085) | 2.52758523 |
| 80 | translation (GO:0006412) | 2.52652449 |
| 81 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.52504394 |
| 82 | pinocytosis (GO:0006907) | 2.52213947 |
| 83 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.48998029 |
| 84 | termination of RNA polymerase III transcription (GO:0006386) | 2.48998029 |
| 85 | folic acid metabolic process (GO:0046655) | 2.48472535 |
| 86 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.47932644 |
| 87 | modulation by virus of host process (GO:0019054) | 2.46934539 |
| 88 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45654080 |
| 89 | tRNA methylation (GO:0030488) | 2.43820236 |
| 90 | ribosomal large subunit biogenesis (GO:0042273) | 2.42871297 |
| 91 | respiratory electron transport chain (GO:0022904) | 2.41722374 |
| 92 | rRNA transcription (GO:0009303) | 2.40322566 |
| 93 | protein retention in ER lumen (GO:0006621) | 2.40264465 |
| 94 | regulation of mitochondrial membrane potential (GO:0051881) | 2.40006102 |
| 95 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.39947366 |
| 96 | regulation of translational termination (GO:0006449) | 2.39433687 |
| 97 | regulation of superoxide anion generation (GO:0032928) | 2.39064442 |
| 98 | negative regulation of cell size (GO:0045792) | 2.38755946 |
| 99 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.37929716 |
| 100 | translational initiation (GO:0006413) | 2.37873230 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.07002848 |
| 2 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.73752740 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.73277600 |
| 4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.57292198 |
| 5 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.50981762 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.31996062 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24545798 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23576944 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22694592 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.20095145 |
| 11 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.10493015 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.08813327 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98909828 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95652118 |
| 15 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90106319 |
| 16 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.89959926 |
| 17 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.87479586 |
| 18 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.85591221 |
| 19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83389094 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.73162046 |
| 21 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.71491757 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.69364468 |
| 23 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.68080147 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65428195 |
| 25 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.63626016 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62105659 |
| 27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61927244 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.60971083 |
| 29 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.60929300 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.60679756 |
| 31 | P68_20966046_ChIP-Seq_HELA_Human | 1.60196838 |
| 32 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.57653263 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57481913 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.55844067 |
| 35 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55294545 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55221954 |
| 37 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.54290366 |
| 38 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.53412802 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.52569715 |
| 40 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.51489879 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50786945 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.50499780 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.50054115 |
| 44 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.49942123 |
| 45 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47520781 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44271202 |
| 47 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.41437372 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.40325240 |
| 49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39982253 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39682020 |
| 51 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.38928770 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.38797096 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37733893 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37206964 |
| 55 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35661660 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33647772 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32516750 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29914723 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29467628 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.25732949 |
| 61 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24711785 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23886307 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23816904 |
| 64 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.23620121 |
| 65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23449233 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.23334498 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.23187537 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23058250 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22926261 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21835868 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.21023536 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19741001 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17702900 |
| 74 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17084019 |
| 75 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16810809 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15702095 |
| 77 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.15550846 |
| 78 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.15344054 |
| 79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14219451 |
| 80 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13809145 |
| 81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13764766 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13750992 |
| 83 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.13177793 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13108175 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12188266 |
| 86 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.11054012 |
| 87 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10960214 |
| 88 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10639561 |
| 89 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10459792 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10052963 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.09965773 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09631537 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09594934 |
| 94 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.09310736 |
| 95 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08809902 |
| 96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08445177 |
| 97 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08257219 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.07966418 |
| 99 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07883213 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06838387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.87038334 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.46725495 |
| 3 | MP0005451_abnormal_body_composition | 3.37482496 |
| 4 | MP0009333_abnormal_splenocyte_physiolog | 3.11481757 |
| 5 | MP0009840_abnormal_foam_cell | 2.55402336 |
| 6 | MP0003436_decreased_susceptibility_to | 2.53403996 |
| 7 | MP0008260_abnormal_autophagy | 2.19073024 |
| 8 | MP0005671_abnormal_response_to | 2.12272739 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.09435077 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.03341226 |
| 11 | MP0005025_abnormal_response_to | 2.01456471 |
| 12 | MP0001835_abnormal_antigen_presentation | 1.99800941 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 1.97835084 |
| 14 | MP0003763_abnormal_thymus_physiology | 1.94042469 |
| 15 | MP0000685_abnormal_immune_system | 1.91023949 |
| 16 | MP0003693_abnormal_embryo_hatching | 1.86268380 |
| 17 | MP0005000_abnormal_immune_tolerance | 1.82767668 |
| 18 | MP0001853_heart_inflammation | 1.81962421 |
| 19 | MP0009785_altered_susceptibility_to | 1.81555093 |
| 20 | MP0000858_altered_metastatic_potential | 1.75675151 |
| 21 | MP0003303_peritoneal_inflammation | 1.72967450 |
| 22 | MP0002723_abnormal_immune_serum | 1.71054981 |
| 23 | MP0001873_stomach_inflammation | 1.70560426 |
| 24 | MP0003186_abnormal_redox_activity | 1.68411664 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.67645415 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.66630015 |
| 27 | MP0001819_abnormal_immune_cell | 1.66617491 |
| 28 | MP0002419_abnormal_innate_immunity | 1.60325330 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.60278409 |
| 30 | MP0001661_extended_life_span | 1.58681603 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.58274709 |
| 32 | MP0005387_immune_system_phenotype | 1.57253462 |
| 33 | MP0001790_abnormal_immune_system | 1.57253462 |
| 34 | MP0001800_abnormal_humoral_immune | 1.56956802 |
| 35 | MP0000490_abnormal_crypts_of | 1.56337624 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.55606491 |
| 37 | MP0003786_premature_aging | 1.54383903 |
| 38 | MP0006082_CNS_inflammation | 1.49691408 |
| 39 | MP0002398_abnormal_bone_marrow | 1.48985996 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.48219078 |
| 41 | MP0000343_altered_response_to | 1.43755719 |
| 42 | MP0000716_abnormal_immune_system | 1.42559065 |
| 43 | MP0005670_abnormal_white_adipose | 1.42103129 |
| 44 | MP0002429_abnormal_blood_cell | 1.40919231 |
| 45 | MP0003172_abnormal_lysosome_physiology | 1.37893420 |
| 46 | MP0002722_abnormal_immune_system | 1.37801350 |
| 47 | MP0009278_abnormal_bone_marrow | 1.34745046 |
| 48 | MP0000678_abnormal_parathyroid_gland | 1.34735363 |
| 49 | MP0005501_abnormal_skin_physiology | 1.32904223 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.31195293 |
| 51 | MP0003075_altered_response_to | 1.30992462 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.30971070 |
| 53 | MP0004947_skin_inflammation | 1.30097703 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.26795765 |
| 55 | MP0008469_abnormal_protein_level | 1.26562660 |
| 56 | MP0000689_abnormal_spleen_morphology | 1.26416411 |
| 57 | MP0003077_abnormal_cell_cycle | 1.24850353 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.24624709 |
| 59 | MP0002405_respiratory_system_inflammati | 1.22111869 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.20232932 |
| 61 | MP0005666_abnormal_adipose_tissue | 1.16545528 |
| 62 | MP0004957_abnormal_blastocyst_morpholog | 1.16484172 |
| 63 | MP0005360_urolithiasis | 1.15735182 |
| 64 | MP0002132_abnormal_respiratory_system | 1.12557020 |
| 65 | MP0002019_abnormal_tumor_incidence | 1.11159464 |
| 66 | MP0004858_abnormal_nervous_system | 1.10760099 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 1.07668694 |
| 68 | MP0000358_abnormal_cell_content/ | 1.04954980 |
| 69 | MP0000313_abnormal_cell_death | 1.04914162 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.04620721 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03147204 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.00879416 |
| 73 | MP0003448_altered_tumor_morphology | 0.95131463 |
| 74 | MP0001764_abnormal_homeostasis | 0.94841917 |
| 75 | MP0003705_abnormal_hypodermis_morpholog | 0.94711509 |
| 76 | MP0005310_abnormal_salivary_gland | 0.93920453 |
| 77 | MP0005330_cardiomyopathy | 0.93718555 |
| 78 | MP0002796_impaired_skin_barrier | 0.93449531 |
| 79 | MP0005083_abnormal_biliary_tract | 0.93236668 |
| 80 | MP0002139_abnormal_hepatobiliary_system | 0.92939816 |
| 81 | MP0004510_myositis | 0.91197551 |
| 82 | MP0008007_abnormal_cellular_replicative | 0.90380187 |
| 83 | MP0001545_abnormal_hematopoietic_system | 0.87371512 |
| 84 | MP0005397_hematopoietic_system_phenotyp | 0.87371512 |
| 85 | MP0009764_decreased_sensitivity_to | 0.84515195 |
| 86 | MP0001542_abnormal_bone_strength | 0.84489330 |
| 87 | MP0005166_decreased_susceptibility_to | 0.83637788 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.83532144 |
| 89 | MP0003866_abnormal_defecation | 0.82672858 |
| 90 | MP0005375_adipose_tissue_phenotype | 0.82120336 |
| 91 | MP0005165_increased_susceptibility_to | 0.79784539 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.79385530 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 0.78888257 |
| 94 | MP0005076_abnormal_cell_differentiation | 0.78323023 |
| 95 | MP0001663_abnormal_digestive_system | 0.76119524 |
| 96 | MP0000609_abnormal_liver_physiology | 0.75447190 |
| 97 | MP0008058_abnormal_DNA_repair | 0.75092458 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.74893862 |
| 99 | MP0001881_abnormal_mammary_gland | 0.74705892 |
| 100 | MP0009931_abnormal_skin_appearance | 0.73135799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 3.61503384 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37072575 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37072575 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37072575 |
| 5 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.36315159 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 3.30652168 |
| 7 | Increased muscle lipid content (HP:0009058) | 3.18793861 |
| 8 | Increased intramyocellular lipid droplets (HP:0012240) | 3.14571321 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.12135790 |
| 10 | Mitochondrial inheritance (HP:0001427) | 3.07096813 |
| 11 | Hepatocellular necrosis (HP:0001404) | 3.00894327 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.99621686 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 2.85662152 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.75222124 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 2.74698882 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 2.72054970 |
| 17 | Hypertensive crisis (HP:0100735) | 2.71759572 |
| 18 | Petechiae (HP:0000967) | 2.67744155 |
| 19 | Abnormal number of erythroid precursors (HP:0012131) | 2.67314302 |
| 20 | Renal Fanconi syndrome (HP:0001994) | 2.66601909 |
| 21 | Progressive muscle weakness (HP:0003323) | 2.63853483 |
| 22 | Dysostosis multiplex (HP:0000943) | 2.63403790 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63211816 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63211816 |
| 25 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61937198 |
| 26 | Rough bone trabeculation (HP:0100670) | 2.58809184 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.58746900 |
| 28 | Hepatic necrosis (HP:0002605) | 2.58581280 |
| 29 | Obstructive lung disease (HP:0006536) | 2.58475257 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.58475257 |
| 31 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.56438087 |
| 32 | Type I transferrin isoform profile (HP:0003642) | 2.56016893 |
| 33 | Increased CSF lactate (HP:0002490) | 2.55560694 |
| 34 | Acute encephalopathy (HP:0006846) | 2.46810252 |
| 35 | Dicarboxylic aciduria (HP:0003215) | 2.44656447 |
| 36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44656447 |
| 37 | Prolonged neonatal jaundice (HP:0006579) | 2.43887324 |
| 38 | Purpura (HP:0000979) | 2.42171982 |
| 39 | Hepatosplenomegaly (HP:0001433) | 2.41036955 |
| 40 | Microretrognathia (HP:0000308) | 2.38439447 |
| 41 | Increased hepatocellular lipid droplets (HP:0006565) | 2.37765361 |
| 42 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.35652230 |
| 43 | Increased serum ferritin (HP:0003281) | 2.32784737 |
| 44 | Thrombocytosis (HP:0001894) | 2.32111509 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.30740618 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.29006673 |
| 47 | Exercise intolerance (HP:0003546) | 2.27806310 |
| 48 | Achilles tendon contracture (HP:0001771) | 2.24651826 |
| 49 | Lactic acidosis (HP:0003128) | 2.24468669 |
| 50 | Abnormal trabecular bone morphology (HP:0100671) | 2.23495292 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.21259855 |
| 52 | Abnormality of macrophages (HP:0004311) | 2.19789611 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.15711929 |
| 54 | Increased serum lactate (HP:0002151) | 2.11270183 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.11223782 |
| 56 | Respiratory difficulties (HP:0002880) | 2.08444812 |
| 57 | Trismus (HP:0000211) | 2.08292820 |
| 58 | Hypokinesia (HP:0002375) | 2.06152822 |
| 59 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05347995 |
| 60 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05347995 |
| 61 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05347995 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.05089164 |
| 63 | Cerebral edema (HP:0002181) | 2.05008016 |
| 64 | Loss of speech (HP:0002371) | 2.01966102 |
| 65 | Eczematoid dermatitis (HP:0000976) | 2.01872278 |
| 66 | Axonal loss (HP:0003447) | 1.99494145 |
| 67 | Abnormal glycosylation (HP:0012345) | 1.98185118 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.98185118 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.98185118 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 1.98185118 |
| 71 | Squamous cell carcinoma (HP:0002860) | 1.97958306 |
| 72 | Abnormality of the Achilles tendon (HP:0005109) | 1.96833545 |
| 73 | Reticulocytopenia (HP:0001896) | 1.96606327 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 1.95767352 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 1.95379608 |
| 76 | Broad distal phalanx of finger (HP:0009836) | 1.94308290 |
| 77 | Myopathic facies (HP:0002058) | 1.93973716 |
| 78 | Progressive macrocephaly (HP:0004481) | 1.93128153 |
| 79 | Seborrheic dermatitis (HP:0001051) | 1.90544617 |
| 80 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.89737713 |
| 81 | Multiple enchondromatosis (HP:0005701) | 1.89155944 |
| 82 | Cutaneous melanoma (HP:0012056) | 1.89032501 |
| 83 | Opisthotonus (HP:0002179) | 1.88839444 |
| 84 | Agammaglobulinemia (HP:0004432) | 1.86955890 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 1.85514930 |
| 86 | Spastic paraparesis (HP:0002313) | 1.83016763 |
| 87 | Pancytopenia (HP:0001876) | 1.82660939 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.81979634 |
| 89 | Mucopolysacchariduria (HP:0008155) | 1.81979634 |
| 90 | Joint stiffness (HP:0001387) | 1.81017336 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 1.79723942 |
| 92 | Esophageal neoplasm (HP:0100751) | 1.78617246 |
| 93 | Neoplasm of head and neck (HP:0012288) | 1.78617246 |
| 94 | Recurrent viral infections (HP:0004429) | 1.78252767 |
| 95 | Cellulitis (HP:0100658) | 1.77230235 |
| 96 | Hypertriglyceridemia (HP:0002155) | 1.77101565 |
| 97 | Respiratory failure (HP:0002878) | 1.76750863 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.76645714 |
| 99 | Bulbar palsy (HP:0001283) | 1.76442710 |
| 100 | Exertional dyspnea (HP:0002875) | 1.76017605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.27428653 |
| 2 | TESK2 | 4.26398742 |
| 3 | VRK2 | 3.98600404 |
| 4 | ERN1 | 3.07172040 |
| 5 | TESK1 | 2.96319310 |
| 6 | IRAK3 | 2.79214895 |
| 7 | SMG1 | 2.72420207 |
| 8 | ARAF | 2.52688256 |
| 9 | PIM2 | 2.45905509 |
| 10 | MAP3K11 | 2.38490534 |
| 11 | KDR | 2.37054647 |
| 12 | BCKDK | 2.19913104 |
| 13 | TRIB3 | 2.15421766 |
| 14 | BUB1 | 2.11909250 |
| 15 | MAP4K1 | 1.99115738 |
| 16 | TAOK2 | 1.95067754 |
| 17 | PRPF4B | 1.76556350 |
| 18 | LIMK1 | 1.58577527 |
| 19 | SIK1 | 1.57527197 |
| 20 | TBK1 | 1.50541633 |
| 21 | MAP2K3 | 1.48858756 |
| 22 | SCYL2 | 1.45815162 |
| 23 | STK16 | 1.43254390 |
| 24 | ABL2 | 1.40850514 |
| 25 | TLK1 | 1.32545229 |
| 26 | BRAF | 1.16767333 |
| 27 | ICK | 1.08176334 |
| 28 | MAPKAPK3 | 1.05254915 |
| 29 | EPHA2 | 1.04718867 |
| 30 | IKBKB | 1.04296985 |
| 31 | PRKD2 | 1.04027727 |
| 32 | MAP3K3 | 1.03478833 |
| 33 | AURKA | 1.03067840 |
| 34 | GRK6 | 0.99936004 |
| 35 | LRRK2 | 0.97979851 |
| 36 | PAK4 | 0.93375819 |
| 37 | NME1 | 0.91107431 |
| 38 | IRAK4 | 0.89114730 |
| 39 | TAOK1 | 0.88048690 |
| 40 | BLK | 0.84842381 |
| 41 | DAPK1 | 0.84429392 |
| 42 | TYK2 | 0.84099335 |
| 43 | ZAP70 | 0.81043864 |
| 44 | ILK | 0.80333089 |
| 45 | IKBKE | 0.78081513 |
| 46 | VRK1 | 0.77040457 |
| 47 | MAP3K8 | 0.76762622 |
| 48 | JAK3 | 0.74911895 |
| 49 | IRAK2 | 0.73281293 |
| 50 | MST1R | 0.72969438 |
| 51 | PRKD3 | 0.72144085 |
| 52 | MAP3K13 | 0.71241563 |
| 53 | MAPK11 | 0.70273748 |
| 54 | PRKCI | 0.67665093 |
| 55 | CDK4 | 0.66389383 |
| 56 | CDK7 | 0.66379883 |
| 57 | TNK2 | 0.66128954 |
| 58 | SIK3 | 0.66088596 |
| 59 | DAPK3 | 0.64429809 |
| 60 | PAK1 | 0.63613644 |
| 61 | EEF2K | 0.61893710 |
| 62 | PBK | 0.60766118 |
| 63 | RPS6KB2 | 0.59045608 |
| 64 | TXK | 0.58604850 |
| 65 | MAP2K2 | 0.56366553 |
| 66 | CDK8 | 0.55998459 |
| 67 | MAP3K1 | 0.55671288 |
| 68 | STK10 | 0.55295239 |
| 69 | PDPK1 | 0.54728255 |
| 70 | PDK2 | 0.53769923 |
| 71 | RPS6KA5 | 0.48826470 |
| 72 | TAF1 | 0.48448083 |
| 73 | CDK9 | 0.44018693 |
| 74 | MOS | 0.40619802 |
| 75 | MAP3K14 | 0.40421767 |
| 76 | CSK | 0.39582788 |
| 77 | MAPKAPK2 | 0.38747388 |
| 78 | LMTK2 | 0.38015506 |
| 79 | CSF1R | 0.36571810 |
| 80 | RPS6KL1 | 0.35615028 |
| 81 | RPS6KC1 | 0.35615028 |
| 82 | PIM1 | 0.35517900 |
| 83 | BTK | 0.35307159 |
| 84 | CHEK2 | 0.34951713 |
| 85 | HIPK2 | 0.33845355 |
| 86 | CDC7 | 0.33676007 |
| 87 | AURKB | 0.32923490 |
| 88 | PRKG2 | 0.31052928 |
| 89 | FES | 0.30198115 |
| 90 | BMX | 0.30068228 |
| 91 | LYN | 0.30056110 |
| 92 | MAP3K10 | 0.29373194 |
| 93 | SYK | 0.28919691 |
| 94 | CSNK1G3 | 0.28674930 |
| 95 | AKT2 | 0.28123628 |
| 96 | LCK | 0.27837692 |
| 97 | PTK6 | 0.26742510 |
| 98 | CCNB1 | 0.26481196 |
| 99 | RPS6KA2 | 0.26250276 |
| 100 | MAP2K6 | 0.25939013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.83070191 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.55090093 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.33044462 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.91789276 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.66093983 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.57372083 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.52002964 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.12846269 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.12494756 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.08260384 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.07099295 |
| 12 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.04908901 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.87246116 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.75136159 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74134525 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.63637546 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.51788909 |
| 18 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.49947536 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49795369 |
| 20 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46077206 |
| 21 | Mismatch repair_Homo sapiens_hsa03430 | 1.42394523 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.41677472 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.40233792 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39877190 |
| 25 | Spliceosome_Homo sapiens_hsa03040 | 1.38690071 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.36990847 |
| 27 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36605837 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36392073 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.35150441 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34166776 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.31317546 |
| 32 | Alzheimers disease_Homo sapiens_hsa05010 | 1.27991168 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27367035 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.24126827 |
| 35 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.16560941 |
| 36 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14832097 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10043827 |
| 38 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.08526869 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.03041900 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.00911571 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98715732 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97999281 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96316002 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 0.95654086 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94921251 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.94800576 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92903066 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92161488 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92050553 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90930655 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.89517721 |
| 52 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89379928 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 0.89157567 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.87617458 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84361871 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.84022759 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.83496814 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81888804 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81395690 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.79927814 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78529168 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.78406739 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77800925 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75839810 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73359749 |
| 66 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.73239551 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69995713 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.69845111 |
| 69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.68077020 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.65482074 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64894117 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63949895 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63908509 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61170021 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59371018 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59360306 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56582522 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.56088644 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55865454 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.55508593 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54830349 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54204661 |
| 83 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53112969 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51972585 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.49134080 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48535796 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.48116563 |
| 88 | Measles_Homo sapiens_hsa05162 | 0.47238418 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45444375 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43634668 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41695433 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39244606 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37553158 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.37486114 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.36792496 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36504847 |
| 97 | Pertussis_Homo sapiens_hsa05133 | 0.35148550 |
| 98 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.34120442 |
| 99 | RNA transport_Homo sapiens_hsa03013 | 0.31979442 |
| 100 | Legionellosis_Homo sapiens_hsa05134 | 0.31390846 |

